Antibody therapeutics are a dominating feature of the current drug development landscape, but increasing costs and time-consuming workflows represent major barriers to their discovery and development.
Researchers from the National University of Singapore (NUS) have developed CellScope, a high-performance single-cell analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results